Bay-Richter, C., et al. “A Role for Inflammatory Metabolites as Modulators of the Glutamate N-Methyl-D-Aspartate Receptor in Depression and Suicidality”. Brain, Behavior, and Immunity 43 (2015): 110–17.
Borrow, A. P., et al. “Estrogenic Mediation of Serotonergic and Neurotrophic Systems: Implications for Female Mood Disorders”. Progress in Neuropsychopharmacology and Biological Psychiatry 54 (2014): 13–25.
Bos, P. A., et al. “Acute Effects of Steroid Hormones and Neuropeptides on Human Social – Emotional Behavior: A Review of Single Administration Studies”. Frontiers in Neuroendocrinology 33, no. 1 (2012): 17–35.
Bouma, E. M. C., et al. “Adolescents’ Cortisol Responses to Awakening and Social Stress; Effects of Gender, Menstrual Phase, and Oral Contraceptives. The TRAILS Study”. Psychoneuroendocrinology 34, no. 6 (2009): 884–93.
Brinton, R. D., et al. “Progesterone Receptors: Form and Function in Brain”. Frontiers in Neuroendocrinology 29, no. 2 (2008): 313–39.
Bunevicius, A., et al. “Hypothalamic-Pituitary-Thyroid Axis Function in Women with a Menstrually Related Mood Disorder: Association with Histories of Sexual Abuse”. Psychosomatic Medicine 74, no. 8 (2012): 810–16.
Carta, M. G., et al. “The Link Between Thyroid Autoimmunity (Antithyroid Peroxidase Autoantibodies) with Anxiety and Mood Disorders in the Community: A Field of Interest or Public Health in the Future”. BMC Psychiatry 4, no. 1 (2004): 25.
Catuzzi, J. E., et al. “Anxiety Vulnerability in Women: A Two-Hit Hypothesis”. Experimental Neurology 259 (2014): 75–80.
Daniel, K., et al. “Contraceptive Methods Women Have Ever Used: United States, 1982–2010”. National Health Statistics Reports 62 (2013): 1–15. https://www.cdc.gov/nchs/data/nhsr/nhsr062.pdf.
Deac, O. M., et al. “Tryptophan Catabolism and Vitamin B-6 Status Are Affected by Gender and Lifestyle Factors in Healthy Young Adults”. Journal of Nutrition 145, no. 4 (2015): 701–7.
Doufas, A. G., et al. “The Hypothalamic-Pituitary-Thyroid Axis and the Female Reproductive System”. Annals of the New York Academy of Sciences 900 (2000): 65–76.
Dreon, D. M., et al. “Oral Contraceptive Use and Increased Plasma Concentration of C-reactive Protein”. Life Sciences 73, no. 10 (2003): 1245–52.
Ervin, K. S., et al. “Estrogen Involvement in Social Behavior in Rodents: Rapid and Long- Term Actions”. Hormones and Behavior 74 (2015): 53–76.
Fröhlich, M., et al. “Oral Contraceptive Use Is Associated with a Systemic Acute Phase Response”. Fibrinolysis and Proteolysis 13, no. 6 (1999): 239–44.
Graham, B. M., et al. “Blockade of Estrogen by Hormonal Contraceptives Impairs Fear Extinction in Female Rats and Women”. Biological Psychiatry 73, no. 4 (2013): 371–78.
Kabat-Zinn, J., et al. “Effectiveness of a Meditation-Based Stress Reduction Program in the Treatment of Anxiety Disorders”. American Journal of Psychiatry 149, no. 7 (1992): 936–43.
Kessler, R. C. “Epidemiology of Women and Depression”. Journal of Affective Disorders 74, no. 1 (2003): 5–13.
Klein, S. L., et al. “Sex Differences in Immune Responses”. Nature Reviews Immunology 16, no. 10 (2016): 626–38.
Kovats, S. “Estrogen Receptors Regulate Innate Immune Cells and Signaling Pathways”. Cellular Immunology 294, no. 2 (2015): 63–69.
Lakhan, S. E., et al. “Nutritional and Herbal Supplements for Anxiety and Anxiety-Related Disorders: A Systematic Review”. Nutrition Journal 9 (2010): 42.
Liu, X., et al. “Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet”. Journal of Agricultural and Food Chemistry 63, no. 36 (2015): 7885–95.
Maeng, L. Y., et al. “Sex Differences in Anxiety Disorders: Interactions Between Fear, Stress, and Gonadal Hormones”. Hormones and Behavior 76 (2015): 106–17.
Mao, J. J., et al. “Rhodiola Rosea Versus Sertraline for Major Depressive Disorder: A Randomized Placebo-Controlled Trial”. Phytomedicine 22, no. 3 (2015): 394–99.
Meier, T. B., et al. “Kynurenic Acid Is Reduced in Females and Oral Contraceptive Users: Implications for Depression”. Brain, Behavior, and Immunity 67 (2018): 59–64.
Miller, A. H., et al. “The Role of Inflammation in Depression: From Evolutionary Imperative to Modern Treatment Target”. Nature Reviews: Immunology 16, no. 1 (2015): 22–34.
Montoya, E. R., et al. “How Oral Contraceptives Impact Social-Emotional Behavior and Brain Function”. Trends in Cognitive Sciences 21, no. 2 (2017): 125–36.
Nehlig, A. “Effects of Coffee/Caffeine on Brain Health and Disease: What Should I Tell My Patients?” Practical Neurology 16, no. 2 (2016): 89–95.
Palmery, M., et al. “Oral Contraceptives and Changes in Nutritional Requirements”. European Review for Medical and Pharmacological Sciences 17, no. 13 (2013): 1804–13.
Pletzer, B. A., et al. “50 Years of Hormonal Contraception: Time to Find Out, What It Does to Our Brain”. Frontiers in Neuroscience 8, no. 8 (2014): 256.
https://www.frontiersin.org /articles/10.3389/fnins.2014.00256/full.
Quaranta, S., et al. “Pilot Study of the Efficacy and Safety of a Modified-Release Magnesium 250 mg Tablet (Sincromag) for the Treatment of Premenstrual Syndrome”. Clinical Drug Investigation 27, no. 1 (2007): 51–58.
Rifai, N., et al. “Population Distributions of C-Reactive Protein in Apparently Healthy Men and Women in the United States: Implication for Clinical Interpretation”. Clinical Chemistry 49, no. 4 (2003): 666–69.
Scheele, D., et al. “Hormonal Contraceptives Suppress Oxytocin-Induced Brain Reward Responses to the Partner’s Face”. Social Cognitive and Affective Neuroscience 11, no. 5 (2016): 767–74.
Skovlund, C. W., et al. “Association of Hormonal Contraception with Depression”. JAMA Psychiatry 73, no. 11 (2016): 1154–62.
Skovlund, C. W., et al. “Association of Hormonal Contraception with Suicide Attempts and Suicides”. American Journal of Psychiatry 175, no. 4 (2018): 336–42.
Smith, C., et al. “A Randomised Comparative Trial of Yoga and Relaxation to Reduce Stress and Anxiety”. Complementary Therapies in Medicine 15, no. 2 (2007): 77–83.
Sorensen, C. J., et al. “Combined Oral Contraception and Obesity Are Strong Predictors of Low-Grade Inflammation in Healthy Individuals: Results from the Danish Blood Donor Study (DBDS)”. PLoS One 9, no. 2 (2014): e88196.
Stomati, M., et al. “Contraception as Prevention and Therapy: Sex Steroids and the Brain”. European Journal of Contraception and Reproductive Health Care 3, no. 1 (1998): 21–28.
Ushiroyama, T., et al. “A Case of Panic Disorder Induced by Oral Contraceptive”. Acta Obstetricia et Gynecologica Scandinavica 71, no. 1 (1992): 78–80.
Van Wingen, G. A., et al. “Gonadal Hormone Regulation of the Emotion Circuitry in Humans”. Neuroscience 191 (2011): 38–45.
